Commonwealth Equity Services’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
Other funds holding ALXO
PFSRSONJ
JF
AHL
CUAMC
EWA
SCM
SS
Commonwealth Equity Services's ALXO Position: Q2 2026 in Review
Commonwealth Equity Services opened a new position in ALX Oncology (ALXO) in Q2 2026: 18,451 shares worth $38.2K. The stake represents ﹤0.01% of the portfolio and ranks #4322 among its holdings. This is a return to the name: Commonwealth Equity Services previously reported a position in ALXO as recently as Q4 2025.
Commonwealth Equity Services first reported a position in ALXO in Q3 2024 and has held it in 7 quarters since. The position peaked at $96K in Q1 2025. 10 funds tracked by Wall St. Rank hold ALXO as of Q2 2026.
- Commonwealth Equity Services held 18,451 shares of ALX Oncology worth $38.2K as of Q2 2026.
- ALX Oncology was a new Commonwealth Equity Services position in Q2 2026.
- ALX Oncology made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #4322 holding.
- Commonwealth Equity Services first reported a position in ALX Oncology in Q3 2024 and has held it in 7 quarters since.
- Commonwealth Equity Services's ALX Oncology position peaked at $96K in Q1 2025.
- 10 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2026.
Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.